Skip to main content
Clinical Trials/NCT00694512
NCT00694512CompletedNot Applicable

Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin

Oregon Health and Science University1 site in 1 country51 target enrollmentStarted: February 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
51
Locations
1
Primary Endpoint
The primary outcomes for aim 1 are the suppression of total and acylated ghrelin from peak fasting (highest value) level to nadir (lowest level) during the 4 hours after each meal, comparing the obese to the lean subjects.

Study Overview

Brief Summary

The purpose of this study is to learn more about how diet affects the hormone ghrelin. Ghrelin is made in the stomach and causes appetite to increase. Learning about ghrelin will help the investigators understand more about obesity.

Detailed Description

Control subjects will be provided 3 different diets for 2 weeks each. At the end of each diet period participants will be admitted to OHSU Clinical Translation Research Center (CTRC) for blood sampling every 30 minutes for 13.5 hours, to measure levels of hormones. Participants will also have a DXA scan to measure body composition.

PWS subjects will have one admission after eating a standardized diet prepared by caregivers for 2 weeks.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age 18 or older.
  • •Weight stable for at least 3 months.
  • •At lifetime maximal body weight.

Exclusion Criteria

  • •Actively losing weight by diet or exercise.
  • •Alcohol consumption > 2 drinks per day.
  • •Exercise > 30 minutes 3 times a week.
  • •Prescription drug use (except birth control pills, vitamins, or minerals).
  • •Type 2 diabetes.
  • •Heart disease, cancer, malabsorptive states, or chronic infections that would affect body weight.
  • •Weight > 300 lbs (exceeds the weight limit of the DEXA machine).
  • •Hemoglobin < 12.0 g/dL for women, < 13.5 g/dL for men

Arms & Interventions

1

Placebo Comparator

low fat diet for two weeks.

Intervention: Low fat diet (Dietary Supplement)

2

Active Comparator

High fat diet for two weeks followed by blood sampling.

Intervention: High fat diet (Dietary Supplement)

3

Active Comparator

Medium Chain Triglyceride diet

Intervention: MCT diet (Dietary Supplement)

Outcomes

Primary Outcomes

The primary outcomes for aim 1 are the suppression of total and acylated ghrelin from peak fasting (highest value) level to nadir (lowest level) during the 4 hours after each meal, comparing the obese to the lean subjects.

Time Frame: every 8 weeks

Secondary Outcomes

  • Area-under-the-curve measurements during the 12 ½ hours of testing for ghrelin and other nutrient and gut-peptides, including glucose, insulin, PYY3-36, and active GLP-1.(Every 8 weeks)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials